EyePoint (EYPT) vs Seer (SEER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Seer (SEER) has outperformed EyePoint (EYPT) over the past year, losing 0.5% versus a loss of 74.9%. Over five years, EYPT leads with a -71.0% price change compared with -93.3% for SEER. EyePoint is the larger company by market cap ($284.6 million vs $121.5 million), about 2.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EYPT | SEER |
|---|---|---|
| Share price | $3.40 | $2.20 |
| Market cap | $284.64M | $121.54M |
| 1-day change | +2.26% | -0.68% |
| YTD return | -81.83% | +20.77% |
| 1-year return | -74.94% | -0.45% |
| 5-year return | -70.98% | -93.30% |
| EPS (TTM) | $-3.75 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.11 | $2.41 |
| 52-week low | $3.05 | $1.55 |
| Distance from 52-week high | -82.23% | -8.92% |
| Analyst consensus | none | none |
| Avg. price target upside | +663.18% | +82.23% |
| Average volume | 3.93M | 481.54K |
| Shares outstanding | 83.84M | 55.37M |
| Employees | 214 | 124 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EyePoint is about 2.3 times larger than Seer by market value ($284.64M vs $121.54M).
- SEER has outperformed EYPT by 74.5 percentage points over the past year.
About EyePoint
EYPT stock →EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Industrials · Biotechnology: Laboratory Analytical Instruments · 214 employees
About Seer
SEER stock →Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Industrials · Biotechnology: Laboratory Analytical Instruments · 124 employees
EYPT vs SEER FAQ
Which is bigger, EyePoint or Seer?
EyePoint (EYPT) is larger, with a market capitalization of $284.64M compared with $121.54M for Seer (SEER).
Which stock has performed better over the past year, EYPT or SEER?
SEER returned -0.45% over the past 12 months, compared with -74.94% for EYPT (price return, excluding dividends). Past performance does not predict future results.
Are EyePoint and Seer in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.